Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression (2017)
- Authors:
- Lima, Hayana Ramos - Universidade de São Paulo (USP)
- Gasparoto, Thaís Helena - Universidade de São Paulo (USP)
- Malaspina, Tatiana Salles de Souza - Universidade de São Paulo (USP)
- Marques, Vinícius Rizzo - Universidade de São Paulo (USP)
- Vicente, Marina Jurado - Universidade de São Paulo (USP)
- Marcos, Elaine Camarinha
- Souza, Fabiana Corvolo
- Nogueira, Maria Renata Sales
- Barreto, Jaison Antônio
- Garlet, Gustavo Pompermaier
- Silva, João Santana da
- Brito-de-Souza, Vânia Nieto
- Campanelli, Ana Paula
- USP affiliated authors: GARLET, GUSTAVO POMPERMAIER - FOB ; SILVA, JOÃO SANTANA DA - FMRP ; CAMPANELLI, ANA PAULA - FOB
- Unidades: FOB; FMRP
- DOI: 10.3389/fimmu.2017.01724
- Subjects: IMUNOTERAPIA; HANSENÍASE; PROTEÍNAS DA MEMBRANA; LINFÓCITOS T
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 8, art. 1724, Dec. 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LIMA, Hayana Ramos et al. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.01724. Acesso em: 13 fev. 2026. -
APA
Lima, H. R., Gasparoto, T. H., Malaspina, T. S. de S., Marques, V. R., Vicente, M. J., Marcos, E. C., et al. (2017). Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01724 -
NLM
Lima HR, Gasparoto TH, Malaspina TS de S, Marques VR, Vicente MJ, Marcos EC, Souza FC, Nogueira MRS, Barreto JA, Garlet GP, Silva JS da, Brito-de-Souza VN, Campanelli AP. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fimmu.2017.01724 -
Vancouver
Lima HR, Gasparoto TH, Malaspina TS de S, Marques VR, Vicente MJ, Marcos EC, Souza FC, Nogueira MRS, Barreto JA, Garlet GP, Silva JS da, Brito-de-Souza VN, Campanelli AP. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fimmu.2017.01724 - Inflammatory mediators in murine squamous cell carcinoma
- Elastase and cytokines in actinic cheilitis and oral squamous cell carcinoma
- CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses
- Patients with Lepromatous Leprosy are characterized by increased frequency of suppressive regulatory T cells in the blood and lesions
- CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction
- Characterization of tumor-infiltrating regulatory T-cell subpopulation in oral squamous cell carcinoma
- Osteoclast costimulatory molecules in periodontitis: Ig/FcRgamma axis involvement in human and experimental disease pathogenesis
- IL-10 and TNF-α differentially modulate the outcome of alveolar bone repair upon homeostatic and infectious conditions
- Células T regulatórias (Tregs) atenuam a severidade da periodontite experimental induzida por A. actinomycetemcomitans via IL-10 e CTLA-4
- Role of the CD14/MyD88 axis in the inflammatory immune response after biomaterial (collagen membrane) grafting in mice
Informações sobre o DOI: 10.3389/fimmu.2017.01724 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
